Subsequent anti-myeloma therapy after maturation antigen (BCMA) chimeric antigen receptor (CAR)-T cell (HDS269B) treatment in patients with relapsed/refractory multiple myeloma

Authors :: Dongjian, Chen
Xiaoxiang, Wang
Zhi, Chen
Songfu, Jiang
Hua, Jiang
Weijun, Fu
Fang, Xiang
Xuedong, Sun
Juan, Du
Source :: American journal of hematologyREFERENCES. 97(12)
Publication Year :: 2022

Subjects :: Receptors, Chimeric Antigen
T-Lymphocytes
Humans
B-Cell Maturation Antigen
Multiple Myeloma
Immunotherapy, Adoptive
Neoplasms, Plasma Cell

Tools